Profile data is unavailable for this security.
About the company
Shanghai Rendu Biotechnology Co Ltd is a China-based company mainly engaged in the research, development, production, and sales of molecular diagnostic reagents and equipment. The Company mainly operates three businesses. The reagent business is mainly engaged in the research, development, production, and sales of molecular diagnostic reagents for reproductive tract infections, respiratory tract infections, enteroviruses, and bloodborne infectious diseases, as well as other reagent products such as sample preservation solutions and nucleic acid extraction reagents. The instrument business is mainly engaged in the research, development, production, and sales of molecular diagnostic instruments such as the fully automated nucleic acid detection and analysis system (AutoSAT). The testing business is mainly engaged in the provision of clinical testing services, including pathogen detection for the genitourinary system, bloodborne pathogens, respiratory system, and digestive system.
- Revenue in CNY (TTM)165.86m
- Net income in CNY-5.47m
- Incorporated2007
- Employees335.00
- LocationShanghai Rendu Biotechnology Co LtdF3 Block 7 #590 Ruiqing RdEast Zone, Zhangjiang High- Tech ParkShanghai 201201ChinaCHN
- Phone+86 2 150720069
- Fax+86 2 150720069
- Websitehttps://www.rdbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Rightongene Biotechnlgy Co Ltd | 191.78m | -27.11m | 1.74bn | 401.00 | -- | 1.93 | -- | 9.08 | -0.4824 | -0.4824 | 3.42 | 16.18 | 0.1954 | 1.29 | 1.14 | 478,253.60 | -4.05 | 2.48 | -4.25 | 2.67 | 70.61 | 69.35 | -20.73 | 7.60 | 13.93 | -- | 0.0028 | 16.94 | -6.16 | -1.05 | -298.78 | -- | -6.04 | -- |
| AVE Science & Technology Co Ltd | 221.12m | 26.95m | 1.96bn | 503.00 | 72.59 | 3.77 | -- | 8.85 | 0.3963 | 0.3963 | 3.25 | 7.62 | 0.3796 | 2.09 | 40.74 | 439,603.90 | 4.63 | 5.20 | 5.19 | 5.87 | 55.98 | 57.49 | 12.19 | 12.48 | 4.47 | -- | 0.0547 | 32.92 | 1.50 | 1.37 | 6.07 | -14.68 | -31.29 | -- |
| Jiangsu Nanfang Medical Co Ltd | 594.86m | -202.28m | 1.96bn | 850.00 | -- | 7.72 | -- | 3.30 | -0.6998 | -0.6998 | 2.06 | 0.88 | 0.5305 | 2.60 | 4.50 | 699,834.10 | -18.06 | -4.62 | -51.29 | -9.50 | -5.00 | 15.52 | -34.03 | -8.29 | 0.2557 | -6.48 | 0.6396 | -- | 0.4199 | 4.15 | -29.34 | -- | -10.48 | -- |
| Suzhou Iron Technology Co Ltd | 381.50m | 5.23m | 2.02bn | 680.00 | 331.77 | 2.60 | -- | 5.30 | 0.079 | 0.079 | 5.10 | 10.06 | 0.2822 | 2.23 | 1.50 | -- | 0.4366 | 4.75 | 0.7154 | 7.34 | 43.10 | 53.91 | 1.55 | 14.71 | 1.20 | 1.29 | 0.2133 | 31.78 | -10.52 | 2.22 | -173.52 | -- | -- | -- |
| Shanghai Rendu Biotechnology Co Ltd | 165.86m | -5.47m | 2.14bn | 335.00 | -- | 2.33 | -- | 12.90 | -0.1374 | -0.1374 | 4.14 | 22.92 | 0.1662 | 1.62 | 2.93 | 495,112.60 | -0.5482 | 4.37 | -0.5875 | 4.91 | 76.46 | 73.71 | -3.30 | 12.61 | 13.50 | -- | 0.0047 | 11.16 | 7.87 | 12.33 | -194.59 | -- | -28.11 | -- |
| Guangzhou LBP Medicine Scnc&Tech Co Ltd | 371.03m | -19.11m | 2.64bn | 796.00 | -- | 2.15 | -- | 7.11 | -0.2042 | -0.2042 | 3.97 | 13.10 | 0.2761 | 1.55 | 1.71 | 466,121.80 | -1.49 | 3.50 | -1.55 | 3.78 | 63.03 | 72.02 | -5.41 | 9.79 | 7.80 | -- | 0.0118 | 32.69 | -5.33 | 5.80 | -46.85 | -22.05 | -7.83 | -- |
| Guangzhou Jet Bio-Filtration Co Ltd | 566.02m | 79.32m | 2.65bn | 1.08k | 35.12 | 2.14 | -- | 4.67 | 0.5367 | 0.5367 | 3.75 | 8.81 | 0.335 | 2.65 | 4.37 | 523,125.40 | 4.81 | 7.56 | 5.10 | 8.33 | 41.07 | 36.85 | 14.35 | 16.26 | 6.46 | 9.35 | 0.2334 | 21.03 | 20.63 | 17.68 | 107.51 | 1.76 | 14.94 | -27.21 |
| Jiangsu Cowin Biotech Co Ltd | 167.17m | -137.72m | 2.87bn | 833.00 | -- | 2.06 | -- | 17.14 | -1.24 | -1.24 | 1.51 | 12.36 | 0.1038 | 1.81 | 2.52 | 200,679.40 | -8.91 | 2.79 | -9.42 | 2.97 | 45.15 | 68.50 | -85.88 | 11.47 | 13.54 | -- | 0.0156 | 32.07 | -26.54 | 11.23 | -86.25 | -- | 34.36 | -- |
| Maider Medical Industry Equipment Co Ltd | 279.92m | -18.77m | 2.90bn | 657.00 | -- | 3.60 | -- | 10.36 | -0.1053 | -0.1053 | 1.68 | 4.85 | 0.249 | 1.07 | 2.08 | 426,058.40 | -3.34 | 5.79 | -4.30 | 6.86 | 34.68 | 49.32 | -13.40 | 16.23 | 1.91 | -- | 0.0705 | 63.92 | -42.77 | 5.58 | -120.02 | -- | 22.08 | -- |
| Jinan High-tech Development Co Ltd | 324.74m | -841.90m | 3.02bn | 565.00 | -- | 68.76 | -- | 9.29 | -1.03 | -1.03 | 0.3748 | 0.0496 | 0.142 | 0.4155 | 0.8567 | 574,762.40 | -39.48 | -8.01 | -161.56 | -27.24 | 16.82 | 28.09 | -277.95 | -31.77 | 0.8954 | -- | 0.283 | -- | -48.02 | -26.91 | -747.31 | -- | -48.67 | -- |
| Shanghai General Hthy Info & Tech Co Ltd | 393.61m | 8.92m | 3.05bn | 355.00 | 348.92 | 2.83 | -- | 7.76 | 0.0644 | 0.0644 | 2.89 | 7.94 | 0.2601 | 3.05 | 0.7735 | 1,108,747.00 | 0.6908 | 7.98 | 0.9681 | 10.00 | 29.15 | 50.08 | 2.66 | 26.00 | 1.82 | 4.30 | 0.1357 | 15.97 | 3.51 | 1.18 | -45.80 | -18.76 | 7.19 | -- |
Data as of Feb 11 2026. Currency figures normalised to Shanghai Rendu Biotechnology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 215.57k | 0.71% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 22.25k | 0.07% |
| Huashang Fund Management Co., Ltd.as of 30 Jun 2025 | 19.50k | 0.06% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 14.38k | 0.05% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 12.65k | 0.04% |
| Fortune & Royal Asset Management Co., Ltd.as of 30 Jun 2025 | 10.62k | 0.04% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 10.11k | 0.03% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 7.25k | 0.02% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 7.11k | 0.02% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 6.74k | 0.02% |
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
